Håkansson, Claes http://orcid.org/0000-0002-6032-2445
Torisson, Gustav
Londos, Elisabet
Hansson, Oskar
Björkman-Burtscher, Isabella M.
van Westen, Danielle
Funding for this research was provided by:
Lund University
Article History
Received: 4 April 2020
Revised: 8 June 2020
Accepted: 11 August 2020
First Online: 26 August 2020
Compliance with ethical standards
:
: The scientific guarantor of this publication is Danielle van Westen.
: The authors of this manuscript declare relationships with the following companies: O.H. has acquired research support (for the institution) from Roche, GE Healthcare, Biogen, AVID Radiopharmaceuticals, Fujirebio, and Euroimmun. In the past 2 years, he has received consultancy/speaker fees (paid to the institution) from Lilly, Roche, and Fujirebio. The other authors declare that they have no conflicts of interest.
: One of the authors has significant statistical expertise. No complex statistical methods were necessary for this paper.
: Written informed consent was waived by the Institutional Review Board.
: Institutional Review Board approval was obtained.
: Some study subjects or cohorts have been previously included in Håkansson et al (2019) Neuroradiology 61:397–404.
: • retrospective• observational• performed at one institution